Favipiravir (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Favipiravir" in Catalan language version.

refsWebsite

Global rank Catalan rank

2^nd place

6^th place

4^th place

7^th place

1^st place

49^th place

152^nd place

145^th place

5,527^th place

309^th place

880^th place

doi.org

«T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections». Antiviral Research, 82, 3, juny 2009, pàg. 95–102. DOI: 10.1016/j.antiviral.2009.02.198. PMID: 19428599.
«Favipiravir (T-705), a novel viral RNA polymerase inhibitor». Antiviral Research, 100, 2, novembre 2013, pàg. 446–54. DOI: 10.1016/j.antiviral.2013.09.015. PMC: 3880838. PMID: 24084488.
«Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever». PLoS Neglected Tropical Diseases, 8, 4, abril 2014, pàg. e2790. DOI: 10.1371/journal.pntd.0002790. PMC: 3983105. PMID: 24722586.
«Zika Virus: Where Is the Treatment?». Current Treatment Options in Infectious Diseases, 8, 3, 2016, pàg. 208–11. DOI: 10.1007/s40506-016-0083-7. PMC: 4969322. PMID: 27547128.
«Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis». The Journal of Infectious Diseases, 213, 8, abril 2016, pàg. 1253–61. DOI: 10.1093/infdis/jiv586. PMC: 4799667. PMID: 26655300.
«Human Rabies - Virginia, 2017» (en anglès americà). MMWR. Morbidity and Mortality Weekly Report, 67, 5152, gener 2019, pàg. 1410–14. DOI: 10.15585/mmwr.mm675152a2. PMC: 6334827. PMID: 30605446.
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews Drug Discovery 2020 Feb doi:10.1038/d41573-020-00016-0

«T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections». Antiviral Research, 82, 3, juny 2009, pàg. 95–102. DOI: 10.1016/j.antiviral.2009.02.198. PMID: 19428599.
«Favipiravir (T-705), a novel viral RNA polymerase inhibitor». Antiviral Research, 100, 2, novembre 2013, pàg. 446–54. DOI: 10.1016/j.antiviral.2013.09.015. PMC: 3880838. PMID: 24084488.
«Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever». PLoS Neglected Tropical Diseases, 8, 4, abril 2014, pàg. e2790. DOI: 10.1371/journal.pntd.0002790. PMC: 3983105. PMID: 24722586.
«Zika Virus: Where Is the Treatment?». Current Treatment Options in Infectious Diseases, 8, 3, 2016, pàg. 208–11. DOI: 10.1007/s40506-016-0083-7. PMC: 4969322. PMID: 27547128.
«Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis». The Journal of Infectious Diseases, 213, 8, abril 2016, pàg. 1253–61. DOI: 10.1093/infdis/jiv586. PMC: 4799667. PMID: 26655300.
«Human Rabies - Virginia, 2017» (en anglès americà). MMWR. Morbidity and Mortality Weekly Report, 67, 5152, gener 2019, pàg. 1410–14. DOI: 10.15585/mmwr.mm675152a2. PMC: 6334827. PMID: 30605446.